Physician profile
Barton Lloyd Wax
NPI 1912197575
$2,969.33
in general payments reported to CMS, 2019-2025
38 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $308 · 2021: $191 · 2022: $380 · 2023: $207 · 2024: $394 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $607.00 | 2019 | |
| Depuy Synthes Sales INC. | $319.47 | 2024-2025 | Va-Lcp, Na, Teligen |
| Stryker Corporation | $230.95 | 2022-2025 | Aequalis Perform Reversed, Triathlon |
| Horizon Therapeutics Plc | $200.71 | 2019-2020 | |
| Wright Medical Technology, INC. | $180.79 | 2019 | |
| Radius Health, INC. | $154.51 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $121.38 | 2022 | |
| Pacira Therapeutics, INC. | $118.71 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $115.39 | 2019-2023 | Euflexxa |
| Globus Medical, INC. | $101.25 | 2023-2025 | Distal Radius Plate, Distal Radius II, Vyrsa V1 |
| Fidia Pharma USA INC. | $85.73 | 2021-2022 | |
| Biocomposites INC | $60.93 | 2025 | Stimulan |
| Kowa Pharmaceuticals America, INC. | $51.90 | 2022-2023 | Seglentis |
| Heron Therapeutics, INC. | $47.02 | 2023-2024 | Zynrelef |
| Vericel Corporation | $43.85 | 2021-2025 | Maci |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40.72 | 2023-2024 | Evenity, Prolia |
| Anika Therapeutics, INC. | $39.35 | 2021-2022 | |
| Orthogenrx INC. | $33.81 | 2019 | |
| Organogenesis INC. | $32.55 | 2025 | Puraply Wound Matrix |
| Pfizer INC. | $32.44 | 2020 | |
| Ethicon US, LLC | $31.05 | 2019-2024 | Stratafix |
| Boston Scientific Corporation | $28.15 | 2019 | |
| Skeletal Dynamics INC | $27.79 | 2024 | Implate, Align, Geminus |
| Si-Bone, INC. | $26.19 | 2020 | |
| Innovation Technologies INC | $23.00 | 2024 | Irrisept |
| Davol INC. | $21.66 | 2025 | Channel Drain |
| Abbott Laboratories | $21.42 | 2021 | |
| Sanara Medtech INC. | $20.26 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.16 | 2022 | |
| Polynovo North America LLC | $16.40 | 2019 | |
| Breg, INC | $15.92 | 2024 | |
| Smith+Nephew, INC. | $15.80 | 2025 | Pico 14 |
| Advanced Oxygen Therapy INC. | $15.70 | 2025 | Topical Oxygen Chamber For Extremities |
| Vertex Pharmaceuticals Incorporated | $14.80 | 2024 | |
| Sonex Health, INC. | $14.27 | 2024 | Sx-One Microknife |
| Abbvie INC. | $14.24 | 2021 | |
| Medacta USA, INC. | $12.89 | 2022 | |
| Heraeus Medical, LLC. | $12.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Wax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.